INTRODUCTION
My theses are (a) most of the time we cannot determine which specific model applies to one or more sets of data, but only which class of model applies ; (b) when linear pharmacokinetics apply, it is usually not necessary to determine which model applies ; and (c) when nonlinear pharmacokinetics apply, it is necessary to obtain a partial or complete model to make accurate predictions.
VARIETY OF SIMPLE PHARMACOKINETIC MODELS AVAILABLE
As part of the defense of the first thesis, a survey will be made of the simple pharmacokinetic models. Figure 1 shows the linear mammillary disposition models with from one to three compartments. A disposition model is one representing bolus intravenous administration of the drug. In each case, the concentration in compartment 1 is assumed to represent the whole blood (plasma or serum) concentration of unchanged drug. There is only one "one-compartment open model"; there are three different "two-compartment open models"; there are 13 "three-compartment open models." Within each class, the differences between the models resides in the compartment or compartments from which aThis paper was presented at the First National Congress on Biopharmaceutics and Pharmacokinetics, Barcelona, Spain, May 12 16, 1975 . The paper, translated into Spanish, will be published in the Proceedings of the Congress following a slightly different format. Linear mammillary disposition models having from one to three compartments. In each case, the concentration in compartment 1 is assumed to represent the measurable concentration of unchanged drug in either whole blood, plasma, or serum.
elimination of drug occurs. In the three-compartment open models, one usually assumes rapid transfer to one of the peripheral compartments and slow transfer or return of drug to and from the other peripheral compartment.
In practice, one decides which class of disposition model applies from the number of exponential terms which are needed to describe the whole blood (plasma or serum) concentration-time curve either following bolus intravenous injection or after a constant-rate intravenous infusion. If only one expo1~ential term is involved, we assign the one-compartment open model. If two exponential terms are involved, we assign the two-compartment open model. If three exponential terms are involved, we assign the threecompartment open model. However, if we measure only in compartment 1 we cannot decide which of the three two-compartment open models or which of the 13 three-compartment open models actually applies to a given set of data. Also, Benet (1) has shown that the number of solvable rate constants, R, is given by equation 1, where n is the number of driving-force compartments.
A driving-force compartment is one having one or more exit rate constants. Hence, for the two-compartment open models, n = 2 and R = 3. Thus, if we assume either model I or II (of the two-compartment open models shown in Fig. 1 ), we can estimate the three rate constantslusually designated kt2 , k21, and kel. However, if we assume model III (of the two-compartment open models shown in Fig. 1 ), we cannot estimate the four rate constants if measurements are made only in compartment 1.
For the three-compartment open models, n = 3 and R = 5. Hence, if we assume that any one of models I, II, III, VI, VII, and VIII applies, we can estimate the five rate constants. However, if we assume that any of the other seven three-compartment open models applies, we can only estimate five of the total of six or seven rate constants. The real problem, however, is that we must assume a particular model; hence the rate constants estimated are peculiar to our arbitrary choice. Table I summarizes the linear mammillary disposition models. The class, number of driving-force compartments, maximum number of microscopic rate constants, number of solvable rate parameters, and number of possible models are listed.
A similar set of mammillary disposition models may be formed by replacing first-order elimination by Michaelis-Menten elimination kinetics (2) . Hence one would have to determine a V,, and a Km value instead of a first-order elimination rate constant. These nonlinear disposition models are summarized in Table II. DiSanto and Wagner (3) introduced nonlinear tissue-binding models. The general scheme is shown in Fig. 2 . It is assumed that there is (are) one or One  1  1  1  1  Two  2  4  3  3  Three  3  7  5  13 Total 17
"A driving-force compartment is one with one or more exit rate constants, n = the number of driving-force compartments. Up to this time, we have been considering only intravenous administration. Suppose now that we consider oral or intramuscular administration. If input to the central compartment is represented by a single first-order rate constant, then for each of the disposition models we obtain one more model. Since there are 17 linear mammillary disposition models and 17 nonlinear disposition models, we obtain 34 more models. The 30 tissue-binding models give 30 more models. We may also have the drug going in both directions across the gastrointestinal barrier (i.e., input to the central compartment would be ~--72 instead of ~); this concept produces a further large number of additional models. We cannot distinguish between these two types of Fig. 3 . If blood levels following oral administration are fitted by a four-term polyexponential equation, and blood levels following intravenous administration are fitted by a two-term polyexponential equation, then there are 27 possible models to explain the data, as shown in Fig. 3 . The disposition portion of the model may be any of the three models shown at the top, and the input portion of the model may be any one of the nine partial models shown at the bottom. It is assumed that the arrowheads on the right-hand side of each of the partial input models at the bottom of Fig. 3 connect with compartment 1 of the disposition models at the top of Fig. 3 . In the example cited, it is very difficult, if not impossible, to determine which of the possible 27 models applies to a particular set of data.
Another difficulty is the "pooling effect." In the tissue-binding models, it is extremely difficult to distinguish plasma protein binding from binding of drug to tissue, or binding of drug to one type of tissue from binding to another type of tissue. This is because, in a certain parameter space, a sum of two Langmuir equations acts like a single "pooled Langmuir equation." Similarly, Sedman and Wagner (4) showed that parallel Michaelis-Menten paths could be "pooled." Also, frequently, parallel Michaelis-Menten and first-order paths may be "pooled" into one Michaelis-Menten path. Table IV summarizes 
AIDS IN CHOOSING A CLASS OF MODELS
Certain types of data aid in choosing a class of model. These are as follows :
a. Whole blood (plasma or serum) concentrations of unchanged drug measured as a function of time following bolus intravenous injection of several doses of the drug. Samples must be collected very shortly after injection and sampling continued long enough to establish the log-linear terminal phase with at least four data points or long enough to be able to estimate the V,, and K m if elimination kinetics are those of Michaelis and Menten. b. Whole blood (plasma or serum) concentrations measured as a function of time following oral administration of two or more doses of the drug given as a solution which dilutes infinitely in the fluids of the gastrointestinal tract without precipitation of the drug. c. Measurement of the major metabolite of the drug in blood (plasma or serum) in the same samples as those in which unchanged drug is measured when experiments (a) and (b) are carried out.
d. Measurement of the unchanged drug and the major metabolite in urine collections obtained at the same time as experiments (a) and (b) are carried out.
WHICH MODEL?
Often it does not matter which specific model of a class of models is chosen. For example, the Loo-Riegelman absorption method (6) assumes that model I of the three possible two-compartment open models (see Fig. 1 ) applies. Recently, Wagner (7) has shown that application of the method will give the correct asymptote and the correct kinetics of absorption in cases where the actual model is any one of the three "three-compartment open models."
The Wagner-Nelson absorption method (8) Minimum steady-state blood levels are often well predicted by a simple monoexponential equation. This does not mean that the one-compartment open model applies, but rather that at z hr after a dose at steady state all exponential terms, except one, are essentially equal to zero'.
WHEN YOU DO NOT NEED A PHARMACOKINETIC MODEL
My second thesis was that when pharmacokinetics are linear it is usually not necessary to determine which specific model applies. I will now defend this thesis by showing how to perform many of the needed calculations without a model in the classical sense.
Bioavailability

First-Pass Effect
The first-pass effect may be assessed using equations 2 and 3 :
Wa~er In these equations, C refers to the whole blood (plasma or serum) concentration at time t, the integrals represent the total area under the concentration-time curve, fm represents the fraction metabolized, 2 represents the whole blood concentration/plasma concentration ratio, and l?b,1, represents the liver blood flow rate. These equations were presented by Rowland (11) and were applied to diphenhydramine by Albert et al. (12) . In equations 2 and 3, 0 represents the fraction of the oral dose which reaches the general circulation intact. The integrals may be estimated using equations 4 and 5: fo ;o
fo fo
The integral on the right-hand side of equation 4 may be estimated by the trapezoidal rule directly from the C, t data; here, T represents the last sampling time of blood in the study. The area from the last sampling time to infinity is estimated by the term on the far right of equation 4; here CT is the concentration at time T and fl is the first-order elimination rate constant estimated from the very terminal C, t data. To use equation 5, one would fit the C, t data to a polyexponential equation using a suitable program and a digital computer and then integrate the resulting equation to obtain the appropriate area.
Efficiency of Absorption
The efficiency of absorption of a drug from a solid oral dosage relative to a solution of the drug may be assessed using equation 6.
Here A refers to the reference (or solution) and B refers to the test solid oral dosage form. If A represents the intravenous route of administration, then the F represents the actual fraction of the oral dose which is absorbed (assuming there is no "first-pass" effect). Use of equation 6 involves the assumption that the plasma clearance remains constant. Wagner (13) has reported on an alternative equation in which the area is multiplied by the fl value obtained for the same set of data.
Rate of Absorption
Rate of absorption may be assessed without a model for linear systems using the deconvolution method introduced by Recigno and Segre (14) and studied extensively by Benet and Chiang (15) . The general equations for the deconvolution method so as to obtain absorption plots and absorption rate constants directly from blood level data are given below for an orally administered drug :
where H(n) is a function describing the blood concentration-time curve following oral administration, F(n) is a function describing the blood concentration-time curve following bolus intravenous administration, and G(n) is the transfer function describing absorption.
From the general equation 8, the equations applicable to calculation of individual values of G i are shown below:
Benet and Chiang (15) recommend use of the point-area (P-A) method rather than the point-point (P-P) or the area-area (A-A) methods. In the point-area (P-A) method, H i is equal to the blood (plasma or serum) concentration at time t i after oral administration and F i is equal to the area under the bolus intravenous blood (plasma or serum) concentration-time curve between ti and t~+ 1-To apply the deconvolution method illustrated here, the blood (plasma or serum) concentrations must be measured at equally spaced time intervals during the absorption phase, but not at other times. The concentrations have to be measured at the same times following both oral and intravenous administration for the time interval that drug is being absorbed after oral administration. The accuracy of the method depends on how close together the samples are taken during the absorption phase. The same situation holds with the Loo-Riegelman method (6,7). Wagner (7) has shown that greater accuracy in application of the Loo-Riegelman method may be obtained by use of interpolated points as well as the observed data points ; the interpolated points were obtained by spiine and Akima methods as reported by Fried and Zeitz (16) . The same interpolation method may be used before application of the deconvolution method. This interpolation method is part of the program AUTOAN (17), which will be described briefly later.
The deconvolution method is illustrated with simulated data in Table V . Equation 14 was used to generate the simulated oral data shown in the fourth column of Table V . Equations 15a and 15b were used to generate the simulated intravenous data and to calculate the area under the curve up to time ti, respectively.
Co~ In this simulation, the oral and intravenous doses were assumed to be equal. The values listed under "G~" in Table V arose by application of equations 9-13 to the numbers shown in the third and fourth columns of the In Gi = -0.4478 -1.0456ti_ a (r = -1.000)
is also shown in the table ; the slope of this line is the estimated value of ko (absorption rate constant). With these error-free data, the rate constant is estimated extremely accurately by the method. One can also calculate values of "fraction of drug remaining at absorption site" as shown in the lower portion of Table V ; these are compared with the actual values found.
To apply the deconvolution method in those cases where the onecompartment open model applies requires only oral data and not intravenous data. This does not appear to have been stated formerly. An illustration is given in Table VI . Once again, equation t4 was used to generate the simulated oral data shown in the fourth column of Table VI. Here oral data were collected long enough to establish the terminal log-linear line shown opposite the data points in the interval 6-12 hr in Table VIo These data were used to generate a C*, t equation (equation 17a) in place of the equation for intravenous administration of the drug. The C*, t equation is integrated stepwise (equation 17b) to obtain areas and the area in each time interval calculated as shown under "F~" in the third column in Table VI In G i = -0.6152 -1.0559t i_ 1 (r = 0.999) (18) is shown below the table ; the slope of this line is the estimated value of k~. In this case, ko was accurately estimated at an error of only 1% with these error-free data using only the simulated oral data. 
Dosage Regimen Calculations (Linear Systems)
All dosage regimen calculations may be performed by fitting either single-dose or steady-state blood (plasma or serum) concentration-time data to simple polyexponential equations, and in some cases by use only of the trapezoidal rule to estimate areas. Model parameters do not have to be derived from the coefficients and exponents of the polyexponential equations. (19) Here, Css(t) refers to the steady-state concentration at time t after a dose at steady-state and r is the uniform dosing interval. To obtain the time of the maximum concentration at steady state, t~ "X, one differentiates equation 20 and sets the derivative equal to zero as shown by equation 21 :
Cl(t ) = ~ I ie -E't
If there are only one or two exponential terms (i.e., n = 1 or 2) in the polyexponential equation, then t~ ~ may be obtained from equation 21 by the use of logarithms; however, if there are three or more terms (i.e., n > 3), then one must solve equation 21 for t~ ~x by an iterative method using an electronic calculator or a digital computer.
Once the value of t~ ax is known, then the maximum concentration at steady state may be calculated with equation 22; the minimum concentration at steady state is given by equation 23 :
I would like to propose that the ratio of the loading dose/maintenance may be calculated using equation 24. This ratio is given by the ratio of the area under the curve during a dosage interval at steady state to the area under the single-dose curve from time 0 to time z. loading dose
_ f~o Cs~(t) dt f~ C~(t) dt
ZI=I Ii/E~ maintenance dose
f~o C,(t) dt f~o Cl(t) dt ~'~=1 (Ii/Ei)(1 -e-E~) (24)
The use of the above equation gives a slightly higher value for the ratio than the method used by Krfiger-Thiemer (18) . A comparison of the two methods is given below for the one-compartment open model with first-order absorption which was always used by Krfiger-Thiemer in dosage regimen calculations : loading dose C~ in 1
maintenance dose
Equations 25 and 26 compare the ratio of the loading dose/maintenance dose for the one-compartment open model with first-order absorption shown. Here k is the absorption rate constant and K is the elimination rate constant. The method of Krfiger-Thiemer (18) is indicated by equation 25 ; in this method, the required ratio is equal to the ratio of the minimum concentration at steady state to the minimum concentration at z hr after the first dose. The method I am proposing gives the ratio equal to the ratio of the average concentration at steady state, Css, to the average concentration from 0 to z hr after the first dose, C1. This is indicated by equation 26. For example, if k = 1.0455, z = 6, and K = 0.17425, then equation 25 gives a value of 1.54 and equation 26 gives a value of 1.73.
If steady-state blood levels are measured at several times after dosing, then one could fit the data to equation 20 rather than using single-dose blood levels to make predictions.
If only minimum steady-state blood levels are measured (i.e., blood levels just before the next dose), such as in the hospital situation, then a model-independent equation is shown as equation 27. This is not useful per se but may be written as either equation 28 or 29 depending on what type of information is available. (19) with digoxin. In this case, the proportionality constant is p.
If one is interested only in average steady-state blood levels, then equations 30-32 apply to linear systems and some nonlinear systems.
Css -FD,
where 
Amount of Drug in the Body
The amount of drug remaining in the body at time t after a bolus intravenous dose may be estimated by measurement of whole blood (plasma or serum) concentrations measured at times t, as shown in the following equations. The concentration-time data are fitted to a polyexponential equation as indicated by equation 34:
The clearance is then calculated with equation 35 :
The amount of drug remaining in the body at time T(AB) is then calculated with equation 36.
The volume of the central compartment, V~, may be estimated with equation 37, and the amount of drug in the central compartment, Ac, at time T calculated with equation 38:
The amount of drug in compartments other than the central compartment at time T, A0, may be calculated with equation 39 :
Analysis of data by hand or electronic calculator is often laborious and requires a prohibitive amount of time. Also, the "answers" obtained by digital computer are often better than the "answers" which may be obtained either by hand or by electronic calculator. Fortunately, the operations involved in pharmacokinetic analysis of data are generally systematic and therefore lend themselves to computer programming and solution by machine.
Sedman and Wagner have arranged to distribute the program AUTOAN (17) on a world-wide basis. AUTOAN is a Fortran IV digital computer program for automatic analysis of concentration-time data described by pharmacokinetic models involving first-order and/or Michaelis 
NONLINEAR PHARMACOKINETICS
My third thesis stated that when nonlinear pharmacokinetics apply it is necessary to obtain a partial or complete model to make accurate predictions. I will indicate some support for this thesis now.
DiSanto and Wagner (3) administered five different doses of methylene blue to a dog at different times by bolus intravenous injection and measured whole blood concentrations as a function of time after each of the doses. Each set of concentration-time data was very well fitted to the equations appropriate to the two-compartment open model with bolus intravenous injection. However, examination of the estimated parameters indicated that the parameters changed with dose. Hence one set of parameters was of no use in making predictions of whole blood concentrations for another dose of the drug. When the same data were fitted to the nonlinear tissue-binding model with one type of fluid and one type of tissue, then consistent values of the parameters were obtained. Also, it was possible to simultaneously fit all five sets of data to the model and estimate only one value of each of A, B, and K from the data. Hence, in this case, the nonlinear model appeared to adequately describe the data and would allow prediction of blood levels following other doses within the same range, and, possibly, outside the range studied.
Historically, it has been assumed that ethyl alcohol is metabolized in man at a zero-order or constant rate and that the evidence for this is a pseudolinear phase in the blood concentration-time curve for some time starting after the peak alcohol concentration and continuing until there is marked curvature at the tail end of the curve on Cartesian coordinate graph paper. Wagner (21) clearly showed that if Michaelis-Menten elimination kinetics apply then the slope of the pseudolinear decline will increase with increase in dose; hence the data cannot be explained by zero-order elimination. In the paper of Wagner (21), this conclusion was reached by a simula-tion technique. However, we now have human data resulting from administration of four different doses of ethanol to eight different subjects which give the same result. We have also data for seven normal volunteers in whom ethanol was infused at a constant rate over a 2-hr period and the entire time course of capillary blood alcohol concentrations followed. The downslope data are fitted well to the one-compartment open model with MichaelisMenten elimination, and application of a modified Wagner-Nelson method allowed back-calculation of the infusion rate with relatively small errors. However, even after publication of the paper of Wagner (21), the zero-order concept is still being repeated (22) . There are still problems in interpreting some ethanol blood concentration data, as our future publications will indicate. However, it does appear that the Michaelis-Menten equation does explain the elimination phase adequately.
